ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P13
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -22.43% |
| Q3 2025 | -23.57% |
| Q2 2025 | -16.26% |
| Q1 2025 | -10.93% |
| Q4 2024 | 26.57% |
| Q3 2024 | -6.82% |
| Q2 2024 | -4.19% |
| Q1 2024 | -3.34% |
| Q4 2023 | -3.31% |
| Q3 2023 | -5.20% |
| Q2 2023 | -5.51% |
| Q1 2023 | -4.53% |
| Q4 2022 | 951.70% |
| Q3 2022 | 158.78% |
| Q2 2022 | -115.02% |
| Q1 2022 | 450.47% |
| Q4 2021 | -109.40% |
| Q3 2021 | -5.35% |
| Q2 2021 | -5.41% |
| Q1 2021 | -3.94% |
| Q4 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 100.00% |
| Q4 2019 | 0.00% |